BackNeoleukin Therapeutics Overview

Neoleukin Therapeutics Current Assets

Neoleukin Therapeutics's current assets is $230M.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$228.91M
↓ 17.95% YoYΔ $-50.07M vs prior year quarter

Peer trimmed avg / median

Loading

Neoleukin Therapeutics Current Assets History

Loading

Neoleukin Therapeutics vs. peers: Current Assets Comparison

Loading

Neoleukin Therapeutics Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Neoleukin Therapeutics (NLTX) FAQ

As of the most recent data (June 2026), NLTX shows a current assets of $230M. That compares with $280M in the prior-year period — down 17.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, NLTX's current assets is now $230M (was $280M) — a 17.9% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Neoleukin Therapeutics is outperforming or lagging.

Tracking NLTX's current assets over time shows whether Neoleukin Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $230M That compares with $280M in the prior-year period — down 17.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Neoleukin Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $230M) with ownership activity and broader fundamentals.

Neoleukin Therapeutics's current assets is $230M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.